Our Mission

The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.

TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer.

24th TRCCC Annual Meeting

Due to our concern for the safety of our members and guests we have made the decision to postpone our 2021 Annual Meeting. The 24th Annual TRCCC meeting will now be held February 16-18, 2022.